ClinicalTrials.govpublic full text
Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)
carcinoma, sorafenib, advanced solid tumors, maximum tolerated dose, carboplatin and paclitaxel chemotherapy combination, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 892089
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.